Gender Differences and Cardiometabolic Risk: The Importance of the Risk Factors

Area of Science:

• Endocrinology
• Cardiology
• Epidemiology

Background:

• Metabolic syndrome (Mets) is a cluster of risk factors including dyslipidemia, hypertension, dysglycemia, and abdominal obesity.
• These factors synergistically increase risks for cardiovascular disease (CVD) and type 2 diabetes.
• Mets doubles CVD risk and increases all-cause mortality by 1.5-fold.

Purpose of the Study:

• To highlight significant gender differences in the epidemiology, etiology, pathophysiology, and clinical presentation of Mets components.
• To discuss sex-based variations in novel biochemical markers associated with Mets and cardiovascular risk.

Main Methods:

• Review and synthesis of existing literature on metabolic syndrome and gender differences.
• Analysis of epidemiological data focusing on sex-specific prevalence and risk factors.
• Examination of studies investigating biochemical markers in relation to gender and metabolic syndrome.

Main Results:

• Significant gender disparities exist in the prevalence and manifestation of individual Mets components.
• Hormonal and genetic factors contribute to differing pathophysiological pathways between sexes.
• Novel biomarkers may exhibit differential utility in assessing cardiovascular risk in men versus women.

Conclusions:

• Understanding gender differences in Mets is crucial for tailored prevention and treatment strategies.
• Further research is needed to elucidate sex-specific mechanisms and validate new biomarkers.
• Addressing these disparities can improve cardiovascular and metabolic health outcomes for both genders.